J&J asked Pfizer and Moderna to help study blood-clot risks but they declined, report says

J&J asked Covid vaccine rivals Pfizer and Moderna to join a study looking into the potential risk of blood clots, the Wall Street Journal reported.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.